Managing cognition in progressive supranuclear palsy.

about

Neurotransmitter deficits from frontotemporal lobar degeneration.The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration.

P2860

Q47837913-15CAC5F1-08F0-4CF7-85C8-5F6EF00CCEAE Q48091480-EE4E7517-508C-4FF4-AB81-48E852DA3AA7

P2860

Managing cognition in progressive supranuclear palsy.

Item

http://www.wikidata.org/entity/Q39017916

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Managing cognition in progressive supranuclear palsy.

@en

Managing cognition in progressive supranuclear palsy.

@nl

type

Item

label

Managing cognition in progressive supranuclear palsy.

@en

Managing cognition in progressive supranuclear palsy.

@nl

prefLabel

Managing cognition in progressive supranuclear palsy.

@en

Managing cognition in progressive supranuclear palsy.

@nl

P1476

Managing cognition in progressive supranuclear palsy

@en

P2093

Ian Ts Coyle-Gilchrist

http://www.w3.org/2001/XMLSchema#string

Timothy Rittman

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study

Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges

Social cognitive deficits and their neural correlates in progressive supranuclear palsy.

Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

Improving response inhibition systems in frontotemporal dementia with citalopram.

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease.

The FAB: a Frontal Assessment Battery at bedside.

P304

499-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NMT-2016-0027

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James B. Rowe

Timothy Rittman

Ian Coyle-Gilchrist

P5008

ScienceSource

P577

2016-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27879155

http://www.w3.org/2001/XMLSchema#string

P921

cognitive disorder

progressive supranuclear palsy

P932

5134756

http://www.w3.org/2001/XMLSchema#string

Managing cognition in progressive supranuclear palsy.

about

P2860

P2860

Managing cognition in progressive supranuclear palsy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932